Clinical re-biopsy of segmental gains—the primary source of preimplantation genetic testing false positives
暂无分享,去创建一个
[1] C. Rubio,et al. PGDIS position statement on the transfer of mosaic embryos 2021. , 2022, Reproductive biomedicine online.
[2] F. Spinella,et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. , 2021, Fertility and sterility.
[3] H. Tournaye,et al. Multiple vitrification-warming and biopsy procedures on human embryos: clinical outcome and neonatal follow-up of children. , 2020, Human reproduction.
[4] K. Choy,et al. The Pregnancy Outcome of Mosaic Embryo Transfer: A Prospective Multicenter Study and Meta-Analysis , 2020, Genes.
[5] Chun-Chia Huang,et al. Clinical Outcomes of Single Mosaic Embryo Transfer: High-Level or Low-Level Mosaic Embryo, Does It Matter? , 2020, Journal of clinical medicine.
[6] L. Gianaroli,et al. Permanence of de novo segmental aneuploidy in sequential embryo biopsies. , 2020, Human reproduction.
[7] C. Simón,et al. Incidence, Origin, and Predictive Model for the Detection and Clinical Management of Segmental Aneuploidies in Human Embryos. , 2020, American journal of human genetics.
[8] J. Horák,et al. Concordance of various chromosomal errors among different parts of the embryo and the value of re-biopsy in embryos with segmental aneuploidies , 2020, Molecular human reproduction.
[9] C. Jalas,et al. When next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) yields an inconclusive report: diagnostic results and clinical outcomes after re biopsy , 2019, Journal of Assisted Reproduction and Genetics.
[10] C. Rubio,et al. PGDIS Position Statement on the Transfer of Mosaic Embryos 2019. , 2019, Reproductive biomedicine online.
[11] B. Lawrenz,et al. The clinicians´ dilemma with mosaicism-an insight from inner cell mass biopsies. , 2019, Human reproduction.
[12] D. Griffin,et al. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies. , 2019, Fertility and sterility.
[13] Chunmin Wang,et al. Transfer of embryos with segmental mosaicism is associated with a significant reduction in live-birth rate. , 2019, Fertility and sterility.
[14] G. Lu,et al. Prevalence and authenticity of de-novo segmental aneuploidy (>16 Mb) in human blastocysts as detected by next-generation sequencing. , 2018, Reproductive biomedicine online.
[15] L. Rienzi,et al. Inconclusive chromosomal assessment after blastocyst biopsy: prevalence, causative factors and outcomes after re-biopsy and re-vitrification. A multicenter experience , 2018, Human reproduction.
[16] M. Traversa,et al. Challenges in interpreting the relevance of segmental mosaicism detected by NGS , 2018 .
[17] M. Gordon,et al. Cellular Stress Associated with Aneuploidy. , 2018, Developmental cell.
[18] M. Traversa,et al. Impact of multiple blastocyst biopsy and vitrification-warming procedures on pregnancy outcomes. , 2017, Fertility and sterility.
[19] D. Wells,et al. The incidence and origin of segmental aneuploidy in human oocytes and preimplantation embryos , 2017, Human reproduction.
[20] L. Arends,et al. Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[21] D. Wells,et al. Analysis of implantation and ongoing pregnancy rates following the transfer of mosaic diploid–aneuploid blastocysts , 2017, Human Genetics.
[22] Parveen Kumar,et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential , 2016, Nature Communications.
[23] P. Padakannaya,et al. Global patterns of large copy number variations in the human genome reveal complexity in chromosome organization. , 2015, Genetics research.
[24] G. Lin,et al. Blastocysts can be rebiopsied for preimplantation genetic diagnosis and screening. , 2014, Fertility and sterility.
[25] P. Boyd,et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe , 2012, European Journal of Human Genetics.
[26] M. Traversa,et al. A molecular strategy for routine preimplantation genetic diagnosis in both reciprocal and Robertsonian translocation carriers. , 2010, Molecular human reproduction.
[27] Tomas W. Fitzgerald,et al. Origins and functional impact of copy number variation in the human genome , 2010, Nature.
[28] Geert Verbeke,et al. Chromosome instability is common in human cleavage-stage embryos , 2009, Nature Medicine.
[29] G. Voglino,et al. De novo balanced chromosome rearrangements in prenatal diagnosis , 2009, Prenatal diagnosis.
[30] R. Jansen,et al. Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations , 2008, Prenatal diagnosis.
[31] D. Warburton,et al. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. , 1991, American journal of human genetics.
[32] N. Treff,et al. Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations. , 2017, Fertility and sterility.
[33] Ashok Agarwal,et al. Cryopreservation of Mammalian Gametes and Embryos , 2017, Methods in Molecular Biology.